HSCSHeartSciences Inc.
- BusinessWire
Fortitude Appoints Jaime Leverton as Chief Executive Officer
Former Hut 8 CEO to Lead Fortitude as the Zcash-Focused, Vertically-Integrated Mining Platform Advances Toward the Public Markets; Andrea Childs to Transition to Chief Operating Officer Fortitude Mining Holdings, ...
- BusinessWire
Fortitude Provides Second Quarter 2026 Financial and Operating Highlights
Fortitude reported strong financial performance with revenue of $20.9 million and Adjusted EBITDA of $8.5 million Continued momentum in core mining operations with approximately 33,646 ZEC mined during the quarter at ...
- GlobeNewswire
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
Fortitude purchased approximately $1,000,000 of HeartSciences’ shares of common stock at $2.43 per share, a 22% premium to the closing price on the purchase dateThe exchange ratio under the merger agreement with ...
- BusinessWire
Fortitude Completes Acquisition of 12.5 MW Prosser, Nebraska Facility
Advances Fortitude's venture mining strategy and further strengthens its owned power portfolio Acquisition marks latest milestone as Fortitude advances toward public markets through proposed combination with ...
- BusinessWire
Fortitude Purchases 9,000 Bitmain Antminer Z15 Pro Units, Deepening Commitment to the Zcash Ecosystem
Purchase reflects a significant investment in Bitmain's industry-leading Zcash miners as the Company continues its proposed business combination with HeartSciences Inc. (NASDAQ:HSCS) Fortitude Mining Holdings, ...
- GlobeNewswire
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company’s shareholders Fiscal 2026 saw the full commercial launch of the MyoVista ...
- BusinessWire
Fortitude Energizes 12 MW Grand Island, Nebraska Facility, Expanding Owned-and-Operated Power Portfolio
Fortitude expands its owned power advantage by energizing its first greenfield build at an attractive power cost Energization expands power portfolio to over 60 MWs of contracted power further supporting Fortitude’s ...
- GlobeNewswire
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
Southlake, TX, July 23, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on ...
- GlobeNewswire
These Emerging Companies Are Racing Toward Major Catalysts
DENVER, June 23, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- Today’s common theme is scale. Whether through regulatory advancement, access to new capital, expanding commercial opportunities, or technological ...
- BusinessWire
Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets
Combined company expected to operate under the Fortitude brand and to trade on Nasdaq under the ticker symbol "TUDE"; transaction expected to close in H2 2026 Upon completion of the transaction, Fortitude ...
- GlobeNewswire
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences' Patent Portfolio to More Than 45 Granted Patents
Southlake, TX, June 11, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ...
- GlobeNewswire
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
Southlake, TX, June 02, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ...
- GlobeNewswire
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
Southlake, TX, May 19, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ...
- GlobeNewswire
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™
Southlake, TX, May 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ...
- GlobeNewswire
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting
Southlake, TX, April 14, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company") a healthcare information technology ("HIT") company focused on advancing electrocardiography ...
- GlobeNewswire
HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
Southlake, TX , March 25, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing ...
- GlobeNewswire
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
Southlake, TX, March 24, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing ...
- Analyst Upgrades
Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $8
Ascendiant Capital analyst Lucas Ward maintains HeartSciences with a Buy and lowers the price target from $9.2 to $8. ...
- GlobeNewswire
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Southlake, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing ...
- GlobeNewswire
University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
Southlake, TX, Feb. 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS; HSCSW), HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company advancing electrocardiography ...
- GlobeNewswire
Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
Southlake, TX, Jan. 29, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing ...
- Analyst Upgrades
Ascendiant Capital Maintains Buy on HeartSciences, Raises Price Target to $9.2
Ascendiant Capital analyst Lucas Ward maintains HeartSciences with a Buy and raises the price target from $9 to $9.2. ...
- GlobeNewswire
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" ...
- GlobeNewswire
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company advancing the use of ECG/EKGs through ...
- GlobeNewswire
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
Southlake, TX, Dec. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company advancing the use of ECG/EKGs through ...